These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22487499)

  • 1. [Reform Act on safety of drug and health products in France: announcement effect, strengthening or upheaval?].
    Maillols-Perroy AC; Tillet Y
    Therapie; 2012; 67(1):1-10. PubMed ID: 22487499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In the wake of the Mediator scandal: some progress in France, but apathy at the European level.
    Prescrire Int; 2012 Apr; 21(126):110. PubMed ID: 22515143
    [No Abstract]   [Full Text] [Related]  

  • 3. European legislators tighten rules on drug safety.
    Watson R
    BMJ; 2012 Sep; 345():e6260. PubMed ID: 22991010
    [No Abstract]   [Full Text] [Related]  

  • 4. Lessons from the Mediator scandal.
    Prescrire Int; 2011 Dec; 20(122):284. PubMed ID: 22216537
    [No Abstract]   [Full Text] [Related]  

  • 5. [Charter of medicines promotion and rational use by physicians].
    Baumevieille M; Bégaud B; Maurain C
    Therapie; 2007; 62(1):39-44. PubMed ID: 17374346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.
    Olivier P; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prescription Drug Marketing Act of 1987.
    Greenberg RB
    Am J Hosp Pharm; 1988 Oct; 45(10):2118-26. PubMed ID: 3228083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New drugs and indications in 2011. France is better focused on patients' interests after the Mediator scandal, but stagnation elsewhere.
    Prescrire Int; 2012 Apr; 21(126):106-10. PubMed ID: 22515141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Summarizing of medicinal alerts in Ivory Coast from 2001 till 2010].
    N'Guessan-Irié AG; Yavo JC; Guillaume Amari AS; Yapi AD
    Therapie; 2012; 67(3):251-6. PubMed ID: 22874492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capacity for a global vaccine safety system: the perspective of national regulatory authorities.
    Graham JE; Borda-Rodriguez A; Huzair F; Zinck E
    Vaccine; 2012 Jul; 30(33):4953-9. PubMed ID: 22658930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediator: who's to blame?
    Braillon A
    Lancet; 2011 Jun; 377(9782):2003-4. PubMed ID: 21665032
    [No Abstract]   [Full Text] [Related]  

  • 12. Mediator: who's to blame?
    Waller P; Evans S
    Lancet; 2011 Jun; 377(9782):2002-3. PubMed ID: 21665030
    [No Abstract]   [Full Text] [Related]  

  • 13. [Update of the French drug reaction assessment method].
    ; Arimone Y; Bidault I; Dutertre JP; Gérardin M; Guy C; Haramburu F; Hillaire-Buys D; Meglio C; Penfornis C; Théophile H; Valnet-Rabier MB
    Therapie; 2011; 66(6):517-25. PubMed ID: 22186077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug scandal exposes French regulators to public ire.
    Casassus B
    Nat Med; 2011 Feb; 17(2):144. PubMed ID: 21297596
    [No Abstract]   [Full Text] [Related]  

  • 15. Veterinary pharmacovigilance. Part 1. The legal basis in the European Union.
    Woodward KN
    J Vet Pharmacol Ther; 2005 Apr; 28(2):131-47. PubMed ID: 15842304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bad medicine: prescription drugs, preemption, and the potential for a no-fault fix.
    Smirniotopoulos A
    Rev Law Soc Change; 2012; 35(4):793-862. PubMed ID: 22363960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of similar biotherapeutic products: scientific and regulatory challenges.
    Griffiths E; Thorpe R; Wadhwa M; Sohn Y
    Biologicals; 2011 Sep; 39(5):249. PubMed ID: 21925898
    [No Abstract]   [Full Text] [Related]  

  • 18. [Interview -- drug legislation -- reporting unexpected adverse drug reactions].
    Ludwig WD
    Pneumologie; 2009 Sep; 63(9):479-80. PubMed ID: 19764017
    [No Abstract]   [Full Text] [Related]  

  • 19. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives.
    Prescrire Int; 2007 Jun; 16(89):126-8. PubMed ID: 17585428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Getting to grips with the new European Union pharmacovigilance legislation.
    Waller P
    Pharmacoepidemiol Drug Saf; 2011 May; 20(5):544-9. PubMed ID: 21394813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.